Elisabeth I Penninga

557 total citations
13 papers, 315 citations indexed

About

Elisabeth I Penninga is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Elisabeth I Penninga has authored 13 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Genetics and 4 papers in Hematology. Recurrent topics in Elisabeth I Penninga's work include Epilepsy research and treatment (3 papers), Kruppel-like factors research (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Elisabeth I Penninga is often cited by papers focused on Epilepsy research and treatment (3 papers), Kruppel-like factors research (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Elisabeth I Penninga collaborates with scholars based in Denmark, Spain and France. Elisabeth I Penninga's co-authors include Niels Graudal, Morten Ladekarl, Gesche Jürgens, Martin Iversen, Daniel A. Steinbrüchel, Christian H. Møller, Christian Gluud, Luit Penninga, Jeppe Bennekou Schroll and Peter C Gøtzsche and has published in prestigious journals such as Cochrane Database of Systematic Reviews, PLoS Medicine and Drugs.

In The Last Decade

Elisabeth I Penninga

13 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth I Penninga Denmark 7 99 67 53 49 41 13 315
Domenico Russo Italy 11 47 0.5× 20 0.3× 24 0.5× 28 0.6× 19 0.5× 32 332
Maury Pinsk Canada 14 40 0.4× 32 0.5× 18 0.3× 22 0.4× 38 0.9× 34 420
Nicolás Medrano Spain 11 28 0.3× 12 0.2× 29 0.5× 17 0.3× 6 0.1× 26 316
Ignazio Di Fazio Italy 11 55 0.6× 46 0.7× 15 0.3× 26 0.5× 11 0.3× 32 480
David S. Cohen United States 9 167 1.7× 113 1.7× 5 0.1× 30 0.6× 8 0.2× 23 354
Ralf Beyrau Germany 9 118 1.2× 9 0.1× 16 0.3× 26 0.5× 10 0.2× 13 499
Dimelza Osorio Spain 9 103 1.0× 2 0.0× 17 0.3× 55 1.1× 26 0.6× 26 355
Pablo Ramírez Spain 15 482 4.9× 38 0.6× 5 0.1× 35 0.7× 9 0.2× 53 718
Mehmet Deniz Aylı Türkiye 9 58 0.6× 15 0.2× 27 0.5× 23 0.5× 13 0.3× 41 270
Tone Gretland Valderhaug Norway 12 386 3.9× 356 5.3× 9 0.2× 9 0.2× 14 0.3× 18 678

Countries citing papers authored by Elisabeth I Penninga

Since Specialization
Citations

This map shows the geographic impact of Elisabeth I Penninga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth I Penninga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth I Penninga more than expected).

Fields of papers citing papers by Elisabeth I Penninga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth I Penninga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth I Penninga. The network helps show where Elisabeth I Penninga may publish in the future.

Co-authorship network of co-authors of Elisabeth I Penninga

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth I Penninga. A scholar is included among the top collaborators of Elisabeth I Penninga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth I Penninga. Elisabeth I Penninga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Penninga, Elisabeth I, Doris Hovgaard, Aldana Rosso, et al.. (2020). EMA Review of Daratumumab (Darzalex) for the Treatment of Adult Patients Newly Diagnosed with Multiple Myeloma. The Oncologist. 25(12). 1067–1074. 4 indexed citations
2.
Tzogani, Kyriaki, Elisabeth I Penninga, Doris Hovgaard, et al.. (2018). EMA Review of Daratumumab for the Treatment of Adult Patients with Multiple Myeloma. The Oncologist. 23(5). 594–602. 17 indexed citations
3.
Schroll, Jeppe Bennekou, Elisabeth I Penninga, & Peter C Gøtzsche. (2016). Assessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers of Trials of Orlistat: A Document Analysis. PLoS Medicine. 13(8). e1002101–e1002101. 44 indexed citations
4.
5.
6.
Penninga, Elisabeth I, Niels Graudal, Morten Ladekarl, & Gesche Jürgens. (2015). Adverse Events Associated with Flumazenil Treatment for the Management of Suspected Benzodiazepine Intoxication – A Systematic Review with Meta‐Analyses of Randomised Trials. Basic & Clinical Pharmacology & Toxicology. 118(1). 37–44. 98 indexed citations
7.
Penninga, Luit, Christian H. Møller, Elisabeth I Penninga, et al.. (2013). Antibody induction therapy for lung transplant recipients. Cochrane Database of Systematic Reviews. 2013(11). CD008927–CD008927. 32 indexed citations
8.
Penninga, Luit, Elisabeth I Penninga, Christian H. Møller, et al.. (2013). Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. Cochrane Database of Systematic Reviews. 2013(5). CD008817–CD008817. 76 indexed citations
9.
Ranjan, Ajenthen G., et al.. (2012). Inheritance of the chronic myeloproliferative neoplasms. A systematic review. Clinical Genetics. 83(2). 99–107. 10 indexed citations
10.
Penninga, Elisabeth I, Helle Kiellberg Larsen, & Stig Ejdrup Andersen. (2008). [Development of sustained vasodilatory shock and permanent loss of hearing after severe lithium carbonate poisoning].. PubMed. 170(5). 354–354. 4 indexed citations
11.
Penninga, Elisabeth I, et al.. (2007). [Nordic accident classification system used in the Danish National Hospital Registration System to register causes of severe traumatic brain injury].. PubMed. 169(45). 3856–60. 3 indexed citations
12.
Penninga, Elisabeth I & Ole Weis Bjerrum. (2006). Polycythaemia Vera and Essential Thrombocythaemia. Drugs. 66(17). 2173–2187. 4 indexed citations
13.
Penninga, Elisabeth I, Per Brinch Hansen, Nielsaage Tøffner Clausen, et al.. (2004). Anagrelide treatment in 52 patients with chronic myeloproliferative diseases. Clinical & Laboratory Haematology. 26(5). 335–340. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Domenico Russo Breakdown of academic impact, for papers by Maury Pinsk Breakdown of academic impact, for papers by Nicolás Medrano Breakdown of academic impact, for papers by Ignazio Di Fazio Breakdown of academic impact, for papers by David S. Cohen Breakdown of academic impact, for papers by Ralf Beyrau Breakdown of academic impact, for papers by Dimelza Osorio Breakdown of academic impact, for papers by Pablo Ramírez Breakdown of academic impact, for papers by Mehmet Deniz Aylı Breakdown of academic impact, for papers by Tone Gretland Valderhaug
Rankless by CCL
2026